Perrigo plc (NYSE:PRGO), the largest maker of over-the-counter healthcare products, is at the center of a years-long legal dispute stemming from its rejection of a takeover bid and subsequent fallout that cost shareholders billions.
The case now includes a battle over whether one of its largest investors, Sculptor Fund, can belatedly remove itself from a related securities class action.
